These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 25917418)

  • 41. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
    Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
    Kolb EA; Kushner BH; Gorlick R; Laverdiere C; Healey JH; LaQuaglia MP; Huvos AG; Qin J; Vu HT; Wexler L; Wolden S; Meyers PA
    J Clin Oncol; 2003 Sep; 21(18):3423-30. PubMed ID: 12972518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
    Ferrari S; Sundby Hall K; Luksch R; Tienghi A; Wiebe T; Fagioli F; Alvegard TA; Brach Del Prever A; Tamburini A; Alberghini M; Gandola L; Mercuri M; Capanna R; Mapelli S; Prete A; Carli M; Picci P; Barbieri E; Bacci G; Smeland S
    Ann Oncol; 2011 May; 22(5):1221-1227. PubMed ID: 21059639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.
    Paioli A; Luksch R; Fagioli F; Tamburini A; Cesari M; Palmerini E; Abate ME; Marchesi E; Balladelli A; Pratelli L; Ferrari S
    J Chemother; 2014 Feb; 26(1):49-56. PubMed ID: 24091100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
    Klingebiel T; Boos J; Beske F; Hallmen E; Int-Veen C; Dantonello T; Treuner J; Gadner H; Marky I; Kazanowska B; Koscielniak E
    Pediatr Blood Cancer; 2008 Apr; 50(4):739-45. PubMed ID: 18286501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.
    Castex MP; Rubie H; Stevens MC; Escribano CC; de Gauzy JS; Gomez-Brouchet A; Rey A; Delattre O; Oberlin O
    J Clin Oncol; 2007 Apr; 25(10):1176-82. PubMed ID: 17401006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
    Ben-Ami T; Waldman E; Marc W; Weintraub M; Revel-Vilk S; Fried I
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):38-42. PubMed ID: 26670840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
    Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
    Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
    Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection.
    Shamberger RC; Laquaglia MP; Krailo MD; Miser JS; Pritchard DJ; Gebhardt MC; Healey JH; Tarbell NJ; Fryer CJ; Meyers PA; Grier HE
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1154-61. PubMed ID: 10838532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P; Angiolillo A; Krailo M; Cheung YK; Anderson B; Davenport V; Reaman G; Cairo MS
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years].
    Jürgens H; Bier V; Dunst J; Harms D; Jobke A; Kotz R; Kühl J; Müller-Weihrich S; Ritter J; Salzer-Kuntschik M
    Klin Padiatr; 1988; 200(3):243-52. PubMed ID: 3145357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
    Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
    J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
    Lee JA; Kim DH; Cho J; Lim JS; Koh JS; Yoo JY; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2011 Jun; 41(6):776-82. PubMed ID: 21415003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893.
    Felgenhauer JL; Nieder ML; Krailo MD; Bernstein ML; Henry DW; Malkin D; Baruchel S; Chuba PJ; Sailer SL; Brown K; Ranganathan S; Marina N
    Pediatr Blood Cancer; 2013 Mar; 60(3):409-14. PubMed ID: 23065953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.